Editas Medicine Inc. (EDIT)
NASDAQ · Healthcare
Editas Medicine Inc. EPS 2016–2025
Editas Medicine Inc. annual/quarterly eps history and growth rate from 2019 to 2026. Earnings per share (EPS) is a company's net profit divided by the number of diluted shares outstanding. Higher EPS generally indicates greater profitability.
- Editas Medicine Inc. eps for the quarter ending March 31, 2026 was $0.26, a 71.74% decrease year-over-year.
- Editas Medicine Inc. annual eps for 2025 was $1.80, a 37.50% decrease from 2024.
- Editas Medicine Inc. annual eps for 2024 was $2.88, a 42.57% increase from 2023.
- Editas Medicine Inc. annual eps for 2023 was $2.02, a 37.07% decrease from 2022.
- Editas Medicine Inc. annual eps for 2022 was $3.21.
EPS
QUARTERLY · USD
YEAR-OVER-YEAR GROWTH · %
Editas Medicine Inc. EPS — FAQ
Editas Medicine Inc. (EDIT) eps over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
What is Editas Medicine Inc.'s eps?
Editas Medicine Inc. (EDIT) reported eps of $-1.80 for fiscal 2025.
Where can I see EDIT's eps history?
The chart and table above show Editas Medicine Inc.'s eps by year and by quarter, including the growth rate.